Failure To Adjuvant Therapy After Pancreatic Resection For Pancreatic Cancer

Study Overview

Failure to Adjuvant Therapy After Pancreatic Resection for Pancreatic Cancer

This study aims to evaluate the rate of patients submitted to pancreatic resection for pancreatic cancer, who fail to access to adjuvant therapy or do not complete adjuvant therapy. The purpose is to give an overview concerning the most frequent conditions and/or reasons associated with failure or omission of adjuvant therapy.

This prospective observational study will evaluate all patients submitted to pancreatic resection for pancreatic cancer. The rate of omission to adjuvant therapy and rate of failure of completion of adjuvant therapy will be evaluated as primary outcomes. As secondary outcomes, survival analyses will be performed to investigate whether these factors influence prognosis, that will be evaluated through a disease free survival analysis at 18-months. Epidemiological and perioperative data will be analyzed to identify conditions associated with the primary outcomes.

Pancreatic Malignant Neoplasm Primary

FOUNTAIN

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates	Results Reporting Dates	Study Record Updates
First Submitted 2018-12-21	Results First Submitted N/A	Last Update Submitted that met QC Criteria 2024-05-06
First Submitted that Met QC Criteria 2018-12-25	Results First Submitted that Met QC Criteria N/A	Last Update Posted (ACTUAL) 2024-05-07
First Posted (ACTUAL) 2018-12-27	Results First Posted N/A	Last Verified 2024-05

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
N/A

Allocation:
N/A

Interventional Model:
N/A

Masking:
N/A

Arms and Interventions

Participant Group/Arm	Intervention/Treatment

Primary Outcome Measures	Measure Description	Time Frame
Rate of patients who fail to receive adjuvant therapy and reasons for that	The amount of patients who will not receive adjuvant therapy after pancreatic resection for malignancy (when do indication exists) will be recorded	6 months
Rate of patients who fail to complete adjuvant therapy and reasons for that	The amount of patients who will not complete adjuvant therapy after pancreatic resection for malignancy will be recorded	9 months

Secondary Outcome Measures	Measure Description	Time Frame
Disease free survival of patients enrolled		18 months

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
18 Years

Accepts Healthy Volunteers:

Histologic diagnosis of pancreatic cancer

Non exocrine pancreatic tumors
Periampullary malignancies

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available

Learn

Resources

Patients

Caregivers

Clinical Trial Record